In situ genetic engineering of tumors for long-lasting and systemic immunotherapy.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: 2020-02-07

DOI: 10.1073/pnas.1916039117

Affiliations: 9

Authors: 6

Institutions	Authors	Share
Johns Hopkins University (JHU), United States of America (USA)		0.37
Translational Tissue Engineering Center (TTEC), JHU, United States of America (USA)		0.30
Institute for NanoBioTechnology (INBT), JHU, United States of America (USA)		0.30
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, United States of America (USA)		0.04

Return

Latest supplement

Nature Index 2021 Asia Pacific

Sustainability, climate-change mitigation, and biomedical science are key areas for future research prowess in the Asia-Pacific region. While COVID-19 travel restrictions have disrupted collaborations between far-flung nations, they have focused attention on vast opportunities for researchers in countries in close proximity and South and southeast Asia to work more closely together on new initiatives.

Access free

Research highlights of partners

Now you see it, now you don’t

Collaborative Innovation Center of Chemical Science and Engineering (Tianjin)

26 Jul 2017

Record breaking fossils

University of New South Wales (UNSW Sydney)

28 Aug 2017

Tiny attackers for treating tumours

Northwestern Polytechnical University (NPU)

2 Apr 2019

Research highlights

Sign up for the free weekly Nature Index newsletter
Sign up